KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Payables: 2009-2024

Historic Payables for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $338.7 million.

  • Exact Sciences' Payables fell 62.69% to $129.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $767.6 million, marking a year-over-year decrease of 25.96%. This contributed to the annual value of $338.7 million for FY2024, which is 329.77% up from last year.
  • Latest data reveals that Exact Sciences reported Payables of $338.7 million as of FY2024, which was up 329.77% from $78.8 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Payables ranged from a high of $348.4 million in FY2020 and a low of $67.8 million during FY2021.
  • Moreover, its 3-year median value for Payables was $78.8 million (2023), whereas its average is $164.2 million.
  • Per our database at Business Quant, Exact Sciences' Payables skyrocketed by 1,199.75% in 2020 and then crashed by 80.53% in 2021.
  • Over the past 5 years, Exact Sciences' Payables (Yearly) stood at $348.4 million in 2020, then plummeted by 80.53% to $67.8 million in 2021, then increased by 10.45% to $74.9 million in 2022, then rose by 5.21% to $78.8 million in 2023, then surged by 329.77% to $338.7 million in 2024.